Norbert G Riedel is EXECUTIVE CHAIRMAN OF THE BOD of Aptinyx Inc.. Currently has a direct ownership of 615,265 shares of APTX, which is worth approximately $0. The most recent transaction as insider was on May 17, 2021, when has been sold 127,274 shares (Common Stock) at a price of $2.53 per share, resulting in proceeds of $322,003. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 615K
0% 3M change
0% 12M change
Total Value Held $0

NORBERT G RIEDEL Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 17 2021
SELL
Payment of exercise price or tax liability
$322,003 $2.53 p/Share
127,274 Reduced 17.14%
615,265 Common Stock
May 17 2021
BUY
Exercise of conversion of derivative security
-
380,000 Added 33.85%
742,539 Common Stock

Also insider at

CERE
Cerevel Therapeutics Holdings, Inc. Healthcare
ETON
Eton Pharmaceuticals, Inc. Healthcare
JAZZ
Jazz Pharmaceuticals plc Healthcare
NGR

Norbert G Riedel

EXECUTIVE CHAIRMAN OF THE BOD
Dublin 4, L2

Track Institutional and Insider Activities on APTX

Follow Aptinyx Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APTX shares.

Notify only if

Insider Trading

Get notified when an Aptinyx Inc. insider buys or sells APTX shares.

Notify only if

News

Receive news related to Aptinyx Inc.

Track Activities on APTX